Results 61 to 70 of about 5,055 (197)

Duplicate Prescription Patterns in Patients With Substance Use Disorders

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT This study sought to investigate the frequency and characteristics of duplicate prescriptions (DPs) in psychiatric inpatients with substance use disorders using a DP classification that differentiates between appropriate DPs (ADPs) and potentially inappropriate DPs (PIDPs). The study was conducted as a monocentric retrospective cross‐sectional
Johannes Heck   +8 more
wiley   +1 more source

Changes in vascular reactivity in experimental hypertensive animals following treatment with indapamide

open access: yes, 1977
Indapamide at doses of 8–16 mg kg−1 day−1, orally, lowered arterial blood pressure (9–26 mm Hg) in conscious renal hypertensive cats during a two week treatment period.
R A Moore, P E Hicks, L Finch
core   +1 more source

Solvent effects on UV-Vis and FT-IR spectra of indapamide combined with DFT calculations

open access: yes, 2020
The present study aimed to analyze the solute-solvent interactions of indapamide using FT-IR, UV-Vis spectroscopies in combination with DFT calculations in four different solvents.
Yalcinkaya, Olcay   +2 more
core   +1 more source

Study of antiatherogenic properties of indapamide in a pharmacologic model

open access: yes, 1993
A localized atheromatous plaque was induced in rabbits after transmural electrical stimulation of the carotid and a cholesterol-rich diet (1.33% cholesterol) for 4 weeks. This model was used to investigate the antiatherogenicity of indapamide.
Robert, R.   +5 more
core   +1 more source

Position of indapamide , a diuretic with vasorelaxant activities, in antihypertensive therapy.

open access: yes, 2012
Introduction: Diuretics play a pivotal role in the management of hypertension. A large experience has been accumulated with indapamide , a long-acting thiazide-like diuretic that lowers blood pressure (BP) primarily through its natriuretic diuretic ...
Feihl, F., Waeber, B., Rotaru, C.
core   +1 more source

PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY

open access: yesРациональная фармакотерапия в кардиологии, 2016
Blood pressure (BP) control in patients with chronic kidney disease is one of the most pressing problems in modern cardiology and nephrology. Perindopril therapy reduces cardiovascular risk in patients with arterial hypertension and nephropathy, provides
O. V. Dralova, M. L. Maksimov
doaj   +1 more source

Resistant Hypertension: Questions and Contemporary Answers

open access: yesРациональная фармакотерапия в кардиологии, 2019
The review presents the important problem of resistant hypertension. Its real prevalence is unknown. According to population studies and metaanalyzes of clinical studies, the prevalence of this most severe form of hypertension reaches 12-15% in the ...
V. I. Podzolkov   +2 more
doaj   +1 more source

Optimal Organ Protection and Blood Pressure Control with the Single Pill Combination Lisinopril, Amlodipine and Indapamide in Arterial Hypertension

open access: yesРациональная фармакотерапия в кардиологии, 2020
Aim. To evaluate the single pill combination with lisinopril, amlodipine and indapamide ability in additional angioprotection achievement in patients with arterial hypertension and high pulse wave velocity (PWV) regardless on previous antihypertensive ...
S. V. Nedogoda   +7 more
doaj   +1 more source

Effects of indapamide on endothelium-dependent relaxations in isolated canine femoral arteries

open access: yes, 1990
Indapamide is an effecctive antihypertensive agent in humans and in experimental hypertensive animals. The aim of the present study was to investigate whether indapamide affects endothelium-dependent and independent relaxations in canine femoral arteries.
Dewey, J, Vanhoutte, PM, Schini, VB
core   +1 more source

Serum lipoproteins during treatment with the antihypertensive agent indapamide

open access: yes, 1985
Considering the documented, potentially undesirable influence of various thiazide-type or loop diuretics on serum lipoproteins, we prospectively investigated in 69 men (mean age +/- SEM, 32 +/- 1 years) the metabolic effects of the new diuretic ...
Bianchetti, MG   +7 more
core  

Home - About - Disclaimer - Privacy